• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100A8的mRNA表达作为非肌层浸润性膀胱癌进展的预后标志物

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer.

作者信息

Ha Yun-Sok, Kim Min-Ju, Yoon Hyung-Yoon, Kang Ho-Won, Kim Yong-June, Yun Seok-Joong, Lee Sang-Cheol, Kim Wun-Jae

机构信息

Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Korea.

出版信息

Korean J Urol. 2010 Jan;51(1):15-20. doi: 10.4111/kju.2010.51.1.15. Epub 2010 Jan 21.

DOI:10.4111/kju.2010.51.1.15
PMID:20414404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2855462/
Abstract

PURPOSE

S100A8 is a member of the S100 protein family containing 2EF-hand calcium-binding motifs. S100 proteins are involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. Altered expression of this protein is associated with various diseases and cancers. The present study aimed to evaluate whether S100A8 has prognostic value for non-muscle-invasive bladder cancer (NMIBC).

MATERIALS AND METHODS

A total of 103 primary NMIBC samples obtained by transurethral resection were evaluated. mRNA levels were examined by real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis. The results were compared with clinico-pathological parameters. The Kaplan-Meier method was applied to plot the curves for progression-free survival. The multivariate Cox regression model was used to identify the independent prognostic factors for progression.

RESULTS

mRNA expression levels of S100A8 were significantly related to the progression of NMIBC. Kaplan-Meier estimates demonstrated significant differences in tumor progression according to the level of S100A8 expression (log-rank test, p<0.001). The multivariate Cox regression model revealed that the S100A8 mRNA expression level (hazard ratio: 12.538; 95% confidence interval: 2.245-70.023, p=0.004) was an independent predictor for disease progression of NMIBC.

CONCLUSIONS

Expression levels of S100A8 might be a useful prognostic marker for disease progression of NMIBC.

摘要

目的

S100A8是S100蛋白家族的成员,含有2个EF手型钙结合基序。S100蛋白参与多种细胞过程的调控,如细胞周期进程和分化。该蛋白表达改变与多种疾病和癌症相关。本研究旨在评估S100A8对非肌层浸润性膀胱癌(NMIBC)是否具有预后价值。

材料与方法

共评估了103例经尿道切除术获取的原发性NMIBC样本。通过实时逆转录聚合酶链反应(RT-PCR)分析检测mRNA水平。将结果与临床病理参数进行比较。采用Kaplan-Meier法绘制无进展生存曲线。使用多变量Cox回归模型确定进展的独立预后因素。

结果

S100A8的mRNA表达水平与NMIBC的进展显著相关。Kaplan-Meier估计显示,根据S100A8表达水平,肿瘤进展存在显著差异(对数秩检验,p<0.001)。多变量Cox回归模型显示,S100A8 mRNA表达水平(风险比:12.538;95%置信区间:2.245 - 70.023,p = 0.004)是NMIBC疾病进展的独立预测因子。

结论

S100A8的表达水平可能是NMIBC疾病进展的有用预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd3/2855462/17f17a79d833/kju-51-15-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd3/2855462/21ee9fc06d7a/kju-51-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd3/2855462/17f17a79d833/kju-51-15-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd3/2855462/21ee9fc06d7a/kju-51-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd3/2855462/17f17a79d833/kju-51-15-g002.jpg

相似文献

1
mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer.S100A8的mRNA表达作为非肌层浸润性膀胱癌进展的预后标志物
Korean J Urol. 2010 Jan;51(1):15-20. doi: 10.4111/kju.2010.51.1.15. Epub 2010 Jan 21.
2
Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer.鉴定 S100A8 相关基因,预测非肌肉浸润性膀胱癌的疾病进展。
BMC Cancer. 2010 Jan 25;10:21. doi: 10.1186/1471-2407-10-21.
3
Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.原发性非肌肉浸润性膀胱癌拓扑异构酶-IIα表达的临床意义及预后价值。
Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.
4
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.PFKFB4 作为非肌肉浸润性膀胱癌的预后标志物。
Urol Oncol. 2012 Nov-Dec;30(6):893-9. doi: 10.1016/j.urolonc.2010.08.018. Epub 2011 Mar 10.
5
Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.DBC1表达降低与非肌层浸润性膀胱癌患者的不良预后相关。
Korean J Urol. 2013 Sep;54(9):631-7. doi: 10.4111/kju.2013.54.9.631. Epub 2013 Sep 10.
6
Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.Ras 相关结构域家族 1A:复发性非肌肉浸润性膀胱癌有前途的预后标志物。
Clin Genitourin Cancer. 2012 Jun;10(2):114-20. doi: 10.1016/j.clgc.2011.12.003. Epub 2012 Feb 28.
7
Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.鉴定 C16orf74 为原发性非肌肉浸润性膀胱癌进展的标志物。
PLoS One. 2010 Dec 21;5(12):e15260. doi: 10.1371/journal.pone.0015260.
8
Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.蜗牛蛋白是预测非肌层浸润性膀胱癌复发和进展的独立预后指标。
Int Urol Nephrol. 2015 Feb;47(2):289-93. doi: 10.1007/s11255-014-0874-z. Epub 2014 Nov 12.
9
HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression.HMOX1 是预测非肌肉浸润性膀胱癌复发和进展的一个重要预后指标。
J Urol. 2011 Feb;185(2):701-5. doi: 10.1016/j.juro.2010.09.081. Epub 2010 Dec 18.
10
Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.Ki-67是非肌肉浸润性膀胱癌(NMIBC)的一个独立指标;欧洲癌症研究与治疗组织(EORTC)风险评分与Ki-67表达相结合可改善NMIBC的风险分层。
Urol Oncol. 2014 Jan;32(1):42.e13-9. doi: 10.1016/j.urolonc.2013.05.004.

引用本文的文献

1
Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation.S100A8在人类实体癌中的预后作用:一项系统评价与验证
Front Oncol. 2020 Nov 9;10:564248. doi: 10.3389/fonc.2020.564248. eCollection 2020.
2
Friend or Foe: S100 Proteins in Cancer.敌友难辨:癌症中的S100蛋白
Cancers (Basel). 2020 Jul 24;12(8):2037. doi: 10.3390/cancers12082037.
3
Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.根治性膀胱切除术后 1 年内骨骼肌指数下降可作为膀胱癌患者的预后指标。

本文引用的文献

1
Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.RUNX3启动子甲基化作为膀胱肿瘤潜在的预后标志物
J Urol. 2008 Sep;180(3):1141-5. doi: 10.1016/j.juro.2008.05.002. Epub 2008 Jul 18.
2
S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.S100A8和S100A9的过表达与乳腺浸润性导管癌的不良病理参数相关。
Curr Cancer Drug Targets. 2008 Jun;8(4):243-52. doi: 10.2174/156800908784533445.
3
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
Int Braz J Urol. 2019 Jul-Aug;45(4):686-694. doi: 10.1590/S1677-5538.IBJU.2018.0530.
4
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).钙粒蛋白 A(S100A8)免疫染色:非肌肉浸润性膀胱癌(NMIBC)患者风险评估的未来候选标志物。
Adv Ther. 2018 Nov;35(11):2054-2068. doi: 10.1007/s12325-018-0789-7. Epub 2018 Sep 19.
5
Clinical and analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.Osteopontin 作为膀胱癌预后指标的临床分析及其下游潜在靶点的揭示。
Int J Biol Sci. 2017 Nov 1;13(11):1373-1386. doi: 10.7150/ijbs.21457. eCollection 2017.
6
Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.犬尿钙卫蛋白在患有下尿路或泌尿生殖道癌的犬中的诊断性能。
BMC Vet Res. 2017 Apr 21;13(1):112. doi: 10.1186/s12917-017-1032-5.
7
Effect of PTEN Gene Mutations and Environmental Risk Factors on the Progression and Prognosis of Bladder Cancer.PTEN基因变异与环境危险因素对膀胱癌进展及预后的影响
Iran J Public Health. 2014 Jan;43(1):56-61.
8
Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.尿细胞学检查作为既往非肌层浸润性膀胱癌患者复发检测常规检查的实用性和成本效益
Korean J Urol. 2014 Oct;55(10):650-5. doi: 10.4111/kju.2014.55.10.650. Epub 2014 Oct 10.
9
S100 protein family in human cancer.人类癌症中的 S100 蛋白家族。
Am J Cancer Res. 2014 Mar 1;4(2):89-115. eCollection 2014.
10
Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer.尿液中无细胞的微小RNA-214作为非肌层浸润性膀胱癌的生物标志物
Korean J Urol. 2013 Nov;54(11):791-6. doi: 10.4111/kju.2013.54.11.791. Epub 2013 Nov 6.
欧洲泌尿外科学会膀胱非肌层浸润性尿路上皮癌指南
Eur Urol. 2008 Aug;54(2):303-14. doi: 10.1016/j.eururo.2008.04.051. Epub 2008 Apr 30.
4
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.非肌层浸润性膀胱癌(Ta、T1和Tis期)管理指南:2007年更新版
J Urol. 2007 Dec;178(6):2314-30. doi: 10.1016/j.juro.2007.09.003.
5
Expression of S100 protein family members in the pathogenesis of bladder tumors.S100蛋白家族成员在膀胱肿瘤发病机制中的表达
Anticancer Res. 2007 Sep-Oct;27(5A):3051-8.
6
A review of the S100 proteins in cancer.癌症中S100蛋白的综述。
Eur J Surg Oncol. 2008 Apr;34(4):357-64. doi: 10.1016/j.ejso.2007.04.009. Epub 2007 Jun 13.
7
The American Joint Committee on Cancer: updating the strategies in cancer staging.美国癌症联合委员会:更新癌症分期策略。
Bull Am Coll Surg. 2002 Jul;87(7):13-5.
8
Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.钙结合蛋白S100A8和S100A9在人胃癌细胞侵袭表型中的作用
Arch Pharm Res. 2007 Jan;30(1):75-81. doi: 10.1007/BF02977781.
9
S100 chemokines mediate bookmarking of premetastatic niches.S100趋化因子介导前转移小生境的标记。
Nat Cell Biol. 2006 Dec;8(12):1321-3. doi: 10.1038/ncb1206-1321.
10
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.使用欧洲癌症研究与治疗组织(EORTC)风险表预测Ta T1期膀胱癌个体患者的复发和进展:来自七项EORTC试验的2596例患者的综合分析
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. doi: 10.1016/j.eururo.2005.12.031. Epub 2006 Jan 17.